Evaluating and predicting clinical outcomes by gene expression analysis
CA 2393136 A1 · Owner: Mcgrath, Michael · Inventors: Mcgrath, Michael; Kuhne, Frederich-Wilhelm; Meuer, Stefan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of determining clinical outcomes in patients sufering from a pathological condition or syndrome are provided. Levels of intracellular gene expression are measured from a clinical sample provided by the patient and , the levels are compared to reference levels. Deviations from reference levels are predictive of clinical outcomes, for example disease progression or , response to therapeutic intervention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 30, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 30, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 30, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.